Indications and uses
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
to prevent motion sickness, take the first dose one hour before starting activity not for frequent or prolonged use except on the advice of a doctor do not exceed recommended dose Adults and children 12 years if age and older Take 1-2 tablets once daily, or as directed by a doctor. Do not exceed 2 tablets in 24 hours.
• TAMPER EVIDENT: Do not use if imprinted seal under cap is broken or missing. • store at room temperature 15˚-30˚C (59˚-86˚F) • protect from humidity
Meclizine HCI 25mg
Antiemetic
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
• breathing problems, such as emphysema or chronic bronchitis
• glaucoma
• difficulty urinating due to an enlarged prostate gland
A sk a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
• drowsiness may occur
• avoid alcoholic beverages
• alcohol, sedatives and tranquilizers may increase drowsiness
• use caution when driving a motor vehicle or operating machinery
I
f
pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| Adults and children 12
years if age and older | Take 1-2 tablets once daily, or as directed by a doctor.
Do not exceed 2 tablets in 24 hours. |
• TAMPER EVIDENT:Do not use if imprinted seal under cap is broken or missing.
• store at room temperature 15˚-30˚C (59˚-86˚F)
• protect from humidity
croscarmellose sodium, D and C yellow no. 10 lake, lactose, magnesium stearate, microcrystalline cellulose, silica, sodium starch glycolate, starch, stearic acid
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68016-778 | 68016-778-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d22f319d-c2c7-3d99-e053-2a95a90a6d23 | 61d29808-e2c0-7f9b-e053-2991aa0a4682 | 2021-12-02 | Warnings | d22f319d-c2c7-3d99-e053-2a95a90a6d23 61d29808-e2c0-7f9b-e053-2991aa0a4682 |
Adverse event summaries are temporarily unavailable. Other product information remains available.